Regeneron Pharmaceuticals

Listing Websites about Regeneron Pharmaceuticals

Filter Type:

Regeneron Pharmaceuticals: Delivering Life-transforming Medicines

(6 days ago) WebDoing well by doing good. Through responsible business practices and with the highest standards of integrity, we rise to any challenge with characteristic drive and a focus on …

Regeneron.com

Category:  Drug Detail Drugs


Investor Relations Regeneron Pharmaceuticals Inc.

(9 days ago) WebFounded by physician-scientists more than 30 years ago, our science-driven approach has resulted in nine FDA-approved medicines and numerous product …

Investor.regeneron.com

Category:  Drug Detail Drugs


REGN Stock Alert: Regeneron Pharmaceuticals Gains on Dupixent …

(5 days ago) WebRegeneron Pharmaceuticals stock is climbing higher on clinical trial data.; A Phase 3 study of Dupixent met its primary endpoint. This has Regeneron closer to the …

Investorplace.com

Category:  Pharmaceutical Detail Drugs


Regeneron Pharmaceuticals - Wikipedia

(5 days ago) OverviewCompany historyExperimental treatment for COVID-19Marketed productsTechnology platformsKey peopleSee alsoExternal linksRegeneron Pharmaceuticals, Inc. is an American biotechnology company headquartered in Westchester County, New York. The company was founded in 1988. Originally focused on neurotrophic factors and their regenerative capabilities, giving rise to its name, the company then branched out into the study of both cytokine and tyrosine kinase receptors.

En.wikipedia.org

Category:  Pharmaceutical Detail Drugs


Dupixent® (dupilumab) Demonstrates Potential to Become First …

(Just Now) WebTARRYTOWN, N.Y. and PARIS, March 23, 2023 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi today announced the …

Investor.regeneron.com

Category:  Pharmaceutical Detail Drugs


Regeneron Pharmaceuticals REGN Stock Price, Company …

(9 days ago) WebRegeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and …

Forbes.com

Category:  Pharmaceutical Detail Drugs


Sanofi, Regeneron unveil 'blow-out' smoker's lung drug data

(9 days ago) WebRegeneron jumped 8.6% in U.S. premarket trade and was set to open at a record high. "COPD is an urgent global health concern and a notoriously difficult-to-treat …

Reuters.com

Category:  Health Detail Drugs


REGN Stock Price Regeneron Pharmaceuticals Inc. Stock Quote …

(8 days ago) WebRegeneron Pharmaceuticals Inc. Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, …

Marketwatch.com

Category:  Pharmaceutical Detail Drugs


Regeneron Clinical Trials

(9 days ago) WebBe part of the discovery—explore Regeneron clinical trials as we work to translate science into medicine for people with serious diseases. Find a relevant clinical trial near you. …

Clinicaltrials.regeneron.com

Category:  Drug Detail Drugs


Regeneron Pharmaceuticals Boosted By COPD Data (NASDAQ:REGN)

(4 days ago) Web1 day ago · Regeneron Pharmaceuticals ( NASDAQ: REGN) is a large cap pharmaceutical company best known for its eye disease therapy Eylea. The release of …

Seekingalpha.com

Category:  Pharmaceutical Detail Drugs


Baird Maintains Neutral Rating for Regeneron Pharmaceuticals: …

(8 days ago) Web2 days ago · Shares of Regeneron Pharmaceuticals are trading up 1.94% over the last 24 hours, at $817.72 per share. A move to $800.00 would account for a 2.17% decline from …

Markets.businessinsider.com

Category:  Pharmaceutical Detail Drugs


Is Regeneron Pharmaceuticals (NASDAQ:REGN) A Risky Investment?

(9 days ago) WebWhat Is Regeneron Pharmaceuticals's Net Debt? As you can see below, Regeneron Pharmaceuticals had US$1.98b of debt, at December 2022, which is about …

Finance.yahoo.com

Category:  Pharmaceutical Detail Drugs


Regeneron Pharmaceuticals Analysts React To Drug Trial Results: …

(3 days ago) Web2 days ago · BMO Capital Markets On Regeneron Pharmaceuticals. Analyst Evan Seigerman maintained an Outperform rating, while raising the price target from $1,025 to …

Benzinga.com

Category:  Pharmaceutical Detail Drugs


Regeneron LinkedIn

(8 days ago) WebRegeneron 358,318 followers on LinkedIn. Get in the Ideas Business. At Regeneron we believe that when the right idea finds the right team, powerful change is possible. As we …

Linkedin.com

Category:  Drug Detail Drugs


Regeneron Pharmaceuticals Inc (REGN) Stock Price & News - Google

(8 days ago) WebRegeneron Pharmaceuticals, Inc. is an American biotechnology company headquartered in Westchester County, New York. The company was founded in 1988. Originally …

Google.com

Category:  Pharmaceutical Detail Drugs